Búsqueda avanzada
Instrumentos
| Nombre | Mnemo | Bolsa de valores | Volumen promedio | Cotización | Tipo | |
|---|---|---|---|---|---|---|
| ELISA OYJ | ELISA | Nasdaq Helsinki +6 Otros | 300 553 |
43,28
EUR
 | Acción | |
| ELISA OYJ | EIA | Deutsche Boerse AG | - |
43,1
EUR
| ||
| ELISA OYJ | 0I8Y | London S.E. | - |
42,98
EUR
| ||
| ELISA OYJ | EIA | Börse Stuttgart | - |
42,92
EUR
| ||
| ELISA OYJ | EIA | BOERSE MUENCHEN | 51 |
43,3
EUR
| ||
| ELISA OYJ | ELMUF | OTC Markets | 1 631 |
45,16
USD
| ||
| ELISA OYJ | EIA | Berne S.E. | - | - CHF
| ||
| ELISA OYJ | ELMUY | OTC Markets | 402 |
24,85
USD
| Acción | |
| ELISA OYJ (EI6) - ELA/C5 | Euronext Amsterdam | - |
43
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/C6 | Euronext Amsterdam | - |
43,37
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/C2 | Euronext Amsterdam | - |
43,43
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/C1 | Euronext Amsterdam | - |
43,29
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/C3 | Euronext Amsterdam | - |
43,56
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/C4 | Euronext Amsterdam | - |
43,72
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/20240620 | Euronext Amsterdam | - |
43,29
EUR
| Futuro | ||
| ELISA OYJ (EI6) - ELA/20240920 | Euronext Amsterdam | - |
43,72
EUR
| Futuro |
Noticias (4)
Empresas (21)
Shiseido Company, Limited está especializada en el diseño, fabricación y comercialización de cosméticos. El grupo ofrece productos de belleza (incluidos artículos de maquillaje, colorantes, etc. ; Shiseido, Aupr's, DQ, Za, Revital Granas, B?n?fique, Maqui ...
Beijing Wantai Biopharmaceutical Co., Ltd. es una empresa dedicada principalmente a la investigación y el desarrollo, la producción y la venta de diagnósticos in vitro. La empresa produce y vende diagnósticos in vitro, equipos de diagnóstico in vitro y va ...
Elisa Oyj es la primera empresa privada de telecomunicaciones de Finlandia. Las ventas netas se desglosan por actividad de la siguiente manera - telefonía móvil (59,2%); - telecomunicaciones fijas (40,8%): servicio telefónico fijo y acceso a Internet de ...
Elis figura entre los líderes europeos en servicios de alquiler y mantenimiento de ropa de mesa y de hogar, ropa de trabajo y equipos de higiene y bienestar. Los servicios se prestan a más de 400.000 empresas que operan en la hostelería y la restauración, ...
Patrizia SE, anteriormente Patrizia AG, es una empresa con sede en Alemania que opera como gestora de inversiones en el mercado inmobiliario. Las actividades empresariales de la empresa incluyen la adquisición, gestión, reposicionamiento y enajenación de ...
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS es una empresa con sede en Turquía que se dedica a la investigación, el desarrollo y la producción de diagnósticos in vitro. Sus productos de diagnóstico incluyen: Microbiología clínic ...
Bioporto A/S es una empresa con sede en Dinamarca dedicada al desarrollo y la comercialización de ensayos de diagnóstico in vitro (DIV). La cartera de la empresa comprende cinco categorías de productos: La prueba de la lipocalina asociada a la gelatinasa ...
Quanterix Corporation es una empresa de ciencias de la vida. La empresa se dedica al desarrollo de plataformas de inmunoensayo digitales ultrasensibles que hacen avanzar la salud de precisión para la investigación y el diagnóstico en ciencias de la vida. ...
Soprocal Calerias e Industrias SA es una empresa con sede en Chile que se dedica a la adquisición y explotación de depósitos minerales, así como a la producción de carbonato de calcio, cal viva, cal apagada, cal hidráulica, así como otros derivados relaci ...
Cheilbio Co., Ltd. es una empresa coreana dedicada a la fabricación de medicamentos veterinarios. La oferta de la empresa consiste en antibióticos, antimicrobianos, lactobacilos, preparados enzimáticos, parasiticidas, antisépticos, oligoelementos orgánico ...
AroCell publ AB es una empresa sueca de diagnóstico dedicada al desarrollo de marcadores para la determinación del crecimiento celular (TK 210) y la apoptosis. El principal producto candidato de la empresa, TK-immuno/hem, es una prueba para la monitorizac ...
American Vietnamese Biotech Incorporation (AmviBiotech) es una empresa con sede en Vietnam dedicada a la industria farmacéutica. La empresa se dedica a la fabricación de medicamentos, vacunas y productos biológicos. También se dedica a la fabricación de p ...
1000mercis está especializada en la prestación de servicios interactivos de publicidad y marketing. Las ventas netas se desglosan por actividad de la siguiente manera - servicios de marketing interactivo (45,2%): desarrolla estudios de segmentos de merca ...
Bioventix plc es una empresa con sede en el Reino Unido especializada en el desarrollo y suministro comercial de anticuerpos monoclonales de alta afinidad para aplicaciones en diagnósticos clínicos, como en inmunoensayos automatizados utilizados en anális ...
Shenzhen Bioeasy Biotechnology Co Ltd es una empresa con sede en China dedicada principalmente a la investigación, el desarrollo, la producción, la venta y el suministro de productos para pruebas de seguridad alimentaria y servicios relacionados. Los prin ...
Spring Art Holdings Berhad es un holding de inversiones con sede en Malasia. La empresa, a través de su filial, Spring Art Industries Sdn. Bhd., se dedica principalmente a la fabricación de productos de mobiliario listos para montar, donde se encarga del ...
Aptamer Group plc es una empresa con sede en el Reino Unido que desarrolla aglutinantes de afinidad personalizados a través de su plataforma Optimer para posibilitar nuevos enfoques en aplicaciones terapéuticas, diagnósticas y de investigación. La platafo ...
Bioqual, Inc. se dedica a la realización de servicios de investigación por contrato, que se centra en modelos in vivo de enfermedades humanas, incluyendo COVID-19, síndrome de inmunodeficiencia adquirida (SIDA), gripe, Mpox, infección por el virus respira ...
ViroGates A/S es una empresa de tecnología médica con sede en Dinamarca. Desarrolla una línea de productos suPARnóstica, que mide la cantidad de proteína receptora activadora del plasminógeno de uroquinasa soluble (suPAR) en la sangre humana. El nivel pla ...
Diadexus, Inc. es una empresa de diagnóstico. La empresa se dedica a desarrollar y comercializar productos que proporcionan a los profesionales sanitarios información relevante para ayudar en la gestión de los pacientes a lo largo del curso de la enfermed ...
Techlab Inc. (Techlab) es un fabricante de productos de diagnóstico para dispositivos médicos. La empresa desarrolla y fabrica diagnósticos intestinales en todo el mundo. Techlab fabrica una variedad de diagnósticos entéricos in vitro para determinar Clos ...
Insiders
En la actualidad, Elisa Patrizi ocupa el cargo de Directora de Operaciones y Mantenimiento en Infrastrutture Wireless Italiane SpA. Anteriormente, la Sra. Patrizi fue Directora de Desarrollo Inalámbrico en Telecom Italia SpA. Se licenció en la Universit degli Studi di Roma Tor Vergata.
Tony Marco Patrizi is the founder of GR Engineering Services Ltd., a company he founded in 2006.
He currently holds the title of Managing Director & Executive Director at the firm.
In addition to his founding position, Mr. Patrizi has also held former positions.
From 2016 to 2018, he served as an Independent Non-Executive Director at Primary Gold Ltd.
He also worked as an Operations Manager at JR Engineering Services Pty Ltd.
Marco Anselmo Patrizi currently works at Morison KSi Ltd., as Director.
Scott Patrizi is a professional with experience in various non-executive director roles.
He is currently a Non-Executive Director at Forrestania Resources Ltd.
Prior to this, he was the President, Chief Executive Officer & Director at Huntsman Exploration, Inc. from 2021 to 2023.
He also served as a Non-Executive Director at Elixir Energy Ltd.
from 2016 to 2019, and at Rarex Ltd.
from 2016 to 2020.
Additionally, he briefly served as a Non-Executive Director at Caprice Resources Ltd.
in 2021.
Patrizi holds an undergraduate degree from The University of Western Australia Business School.
Elisa Massimino is a Trustee at the McCain Institute for International Leadership.
Previously, she served as the President & Chief Executive Officer at Human Rights First.
Elisa Coletti is an economist who currently works at Intesa Sanpaolo.
SpA (Broker) as an Economist Banks.
Elisa Burns has been a Trustee at Northern Westchester Hospital Association since 2013.
Dr. Elisa Newby is an Economist at Bank of Finland.
Her current areas of responsibility include preparation of the Bank of Finland’s macroeconomic forecasts and development of forecasting systems and models.
Prior to this she has worked as a lecturer at the University of Cambridge and a researcher at the Centre for Dynamic Macroeconomic Analysis (CDMA) at the University of St Andrews in Scotland.
In 2002–2004, Dr. Newby worked in the Bank of Finland’s Statistics Department, where she was responsible for compiling balance of payments statistics.
In 1999–2002, she served as a derivatives expert on the Helsinki Stock Exchange.
Dr. Newby completed her PhD in Economics at the CDMA in 2007.
Her doctoral dissertation dealt with sustainable monetary policy.
She also has a Master’s degree in Social Sciences from the University of Helsinki.
Elisa DiTommaso has worked as a Director at Heritage Valley Health System, Inc. since 2013.
Elisa Rusu worked at Banca Transilvania SA from 2009 to 2017 as a Manager in the Factoring Department.
Elisa M.
Wilson is currently serving as an Independent Non-Executive Director at GAMCO Investors, Inc. since 2009.
She is also a Director at GGCP, Inc., Associated Capital Group, Inc., and the American Red Cross of Greater New York.
Additionally, she holds positions as a Director at the Breast Cancer Alliance, Member-BPA Board at Brunswick School, Inc., and Trustee at Boston College.
Ms. Wilson has been the President & Trustee of the Gabelli Foundation, Inc. since 2009.
In terms of education, she has a graduate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Boston College.
Ms. Elisa Brizuela is a Senior Equity Trader at Segall Bryant & Hamill LLC.
Ms. Brizuela is responsible for Segall Bryant & Hamill's Small Cap Equity trading, as well as assisting institutional equity trading.
She has been in the investment industry since 1987.
Prior to joining the firm, she was an international equity trader at Driehaus Capital Management and William Blair Asset Management.
Ms. Elisa Dannemiller is Chief Medical Officer at Sharklet Technologies, Inc. and a Member at American College of Emergency Physicians.
Ms. Dannemiller was previously employed as a Principal by McKinsey & Co., Inc. She also served on the board at The Denver Business Series.
She received her undergraduate degree from the University of Virginia.
Elisa Magro is the founder of The Amazing Food Co. Srl, which was founded in 2011.
Elisa Grandizio is associated with RantNetwork, Inc. as the founder and holds the title of Chief Administrative Officer since 2006.
Ms. Elisa Machado is a Senior Economist at ARX Investimentos Ltda.
She was previously employed as Economist by Aria Capital, Economic Consultant by Atico Administração de Recursos Ltda., Economist by Icatu Gestão Patrimonial Ltda., Opus Gestão de Recursos Ltda., FUNCEX - Foreign Trade Studies Center Foundation and Bank of America, Consultnat by CBIE – Brazilian Center of Infrastructure, Researcher by IPEA - Institute for Applied Economic Research and Lecturer by PUC-Rio (1996) and Ibmec (2000).
Ms. Machado holds a degree in Economics from Universidade Federal Fluminense and Master's in Economics from Pontifícia Universidade Católica do Rio de Janeiro.
Elisa Waldeck is a Member of The Institute of Directors, her current job.
In the past, she worked as a Secretary at Blue Financial Services Ltd.
from 2011 to 2012.
Elisa Rizza Trelewicz is currently working as Vice President & Senior Securities Analyst at Columbus Circle Investors since 2001.
She completed her undergraduate degree from the University of Connecticut in 2000.
Elisa Jagerson is a Managing Director at Wildcat where she focuses on investments in Climate Tech SaaS solutions that reduce the effects of climate change.
Her specific areas of interest include AI and Machine Learning (ML) enabled platforms that create disruptive levels of foresight into a future perceived to be unpredictable.
Elisa was most recently CEO of FutureBrand Speck, best known for driving product and service innovation to both market disrupters and industry leaders.
Organizations turned to Elisa and her teams of brand, product, environment and service designers when they needed to accelerate or ‘future proof’ growth.
These products sit today inside our pockets, bodies, hospitals, cars, and data centers, and have generated billions in revenue.
After pioneering ‘experience engineering’, a next generation design thinking methodology credited with infusing reliability into the innovation process, Elisa sold Speck Design to FutureBrand (NYSE: IPG), where she then served on the global leadership team.
Earlier in her career as Founder and CEO of PartsRiver, Elisa pioneered early intelligent data management (IDM) in the transportation industry.
There she acquired $150M in assets from Saqqara and CDC (a Boeing subsidiary), growing PartsRiver into the leading provider of IDM.
Following her success at PartsRiver, Elisa launched and ran Bay Laurel Capital, a micro-cap leveraged buyout firm affiliated with AI LLC.
Elisa began her finance career in global emerging markets, making investments at New York-based private equity firm Zephyr Management and Harare-based ZPF.
Elisa received a BA Cum Laude from Princeton University and an MBA from the Wharton School of Business.
Elisa Dozono currently works as a Director at Oregon Public Broadcasting.
Elisa Vigna is the founder and director of Metis Precision Medicine Sb Srl, which is founded in 2017.
Elisa Davies currently works at Opera Omaha Guild, as Chairman, The Nebraska Humane Society, as Director, and HDR Engineering, Inc., as Governor.
No hay resultados para esta búsqueda
- Bolsa de valores
- Búsqueda avanzada
- Elisa Patrizi
